SPIN3
gene geneOn this page
Also known as TDRD27
Summary
SPIN3 (spindlin family member 3, HGNC:27272) is a protein-coding gene on chromosome Xp11.21, encoding Spindlin-3 (Q5JUX0). Exhibits H3K4me3-binding activity.
Enables methylated histone binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in membrane. Predicted to be active in cytosol and nucleoplasm.
Source: NCBI Gene 169981 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 52 total
- Druggable target: yes
- MANE Select transcript:
NM_001010862
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27272 |
| Approved symbol | SPIN3 |
| Name | spindlin family member 3 |
| Location | Xp11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TDRD27 |
| Ensembl gene | ENSG00000204271 |
| Ensembl biotype | protein_coding |
| Entrez | 169981 |
Gene structure
Transcript identifiers
Ensembl transcripts: 45 — 33 nonsense_mediated_decay, 10 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000374919, ENST00000475785, ENST00000478405, ENST00000638257, ENST00000638289, ENST00000638341, ENST00000638386, ENST00000638481, ENST00000638619, ENST00000638664, ENST00000638712, ENST00000638819, ENST00000638834, ENST00000638845, ENST00000638873, ENST00000638940, ENST00000639000, ENST00000639007, ENST00000639053, ENST00000639257, ENST00000639418, ENST00000639482, ENST00000639525, ENST00000639583, ENST00000639605, ENST00000639607, ENST00000639791, ENST00000639794, ENST00000639809, ENST00000639888, ENST00000639895, ENST00000639956, ENST00000640039, ENST00000640101, ENST00000640104, ENST00000640131, ENST00000640187, ENST00000640421, ENST00000640463, ENST00000640507, ENST00000640511, ENST00000640577, ENST00000640717, ENST00000640728, ENST00000640768
RefSeq mRNA: 1 — MANE Select: NM_001010862
NM_001010862
CCDS: CCDS43963
Canonical transcript exons
ENST00000374919 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001932860 | 56990831 | 56994949 |
| ENSE00003805021 | 56995216 | 56995541 |
Expression profiles
Bgee: expression breadth ubiquitous, 212 present calls, max score 96.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.5948 / max 79.8529, expressed in 1544 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199425 | 5.0024 | 1530 |
| 199424 | 0.5924 | 287 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 96.21 | gold quality |
| oocyte | CL:0000023 | 92.17 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.07 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 88.95 | gold quality |
| cerebellar cortex | UBERON:0002129 | 88.92 | gold quality |
| cortical plate | UBERON:0005343 | 88.26 | gold quality |
| cerebellum | UBERON:0002037 | 87.89 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.32 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.54 | gold quality |
| adenohypophysis | UBERON:0002196 | 83.41 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.34 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.07 | gold quality |
| hypothalamus | UBERON:0001898 | 82.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.92 | gold quality |
| tibial nerve | UBERON:0001323 | 82.90 | gold quality |
| right ovary | UBERON:0002118 | 82.80 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 82.80 | gold quality |
| nucleus accumbens | UBERON:0001882 | 82.53 | gold quality |
| caudate nucleus | UBERON:0001873 | 82.45 | gold quality |
| left ovary | UBERON:0002119 | 82.30 | gold quality |
| pituitary gland | UBERON:0000007 | 82.25 | gold quality |
| right lobe of liver | UBERON:0001114 | 82.04 | gold quality |
| endocervix | UBERON:0000458 | 81.99 | gold quality |
| body of pancreas | UBERON:0001150 | 81.93 | gold quality |
| putamen | UBERON:0001874 | 81.77 | gold quality |
| neocortex | UBERON:0001950 | 81.77 | gold quality |
| frontal cortex | UBERON:0001870 | 81.65 | gold quality |
| calcaneal tendon | UBERON:0003701 | 81.59 | gold quality |
| body of uterus | UBERON:0009853 | 81.54 | gold quality |
| endothelial cell | CL:0000115 | 81.53 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
93 targeting SPIN3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-4658 | 99.77 | 64.94 | 514 |
| HSA-MIR-6790-5P | 99.77 | 65.24 | 505 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spinb | ENSDARG00000035697 |
| danio_rerio | spina | ENSDARG00000058949 |
Paralogs (4): SPIN1 (ENSG00000106723), SPIN2A (ENSG00000147059), SPIN4 (ENSG00000186767), SPIN2B (ENSG00000186787)
Protein
Protein identifiers
Spindlin-3 — Q5JUX0 (reviewed: Q5JUX0)
Alternative names: Spindlin-like protein 3
All UniProt accessions (6): A0A1W2PPF7, A0A1W2PPL1, A0A1W2PQU8, A0A1W2PR54, A0A1W2PRP6, Q5JUX0
UniProt curated annotations — full annotation on UniProt →
Function. Exhibits H3K4me3-binding activity.
Subunit / interactions. Interacts with C11orf84/SPINDOC.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the SPIN/STSY family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5JUX0-1 | 1 | yes |
| Q5JUX0-2 | 2 |
RefSeq proteins (1): NP_001010862* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003671 | SPIN/Ssty | Family |
| IPR042567 | SPIN/Ssty_sf | Homologous_superfamily |
Pfam: PF02513
UniProt features (31 total): strand 15, region of interest 6, site 3, splice variant 2, helix 2, chain 1, sequence conflict 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5A1H | X-RAY DIFFRACTION | 2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JUX0-F1 | 81.63 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 169 (histone h3k4me3 and h3r8me2a binding); 176 (histone h3k4me3 and h3r8me2a binding); 180 (histone h3k4me3 and h3r8me2a binding)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
FISCHER_G1_S_CELL_CYCLE, TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN, ZHAN_MULTIPLE_MYELOMA_MS_DN, WHITFIELD_CELL_CYCLE_G1_S, chrXp11, PEDRIOLI_MIR31_TARGETS_DN, ZWANG_DOWN_BY_2ND_EGF_PULSE, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, MIR548E_5P, MIR10527_5P, MIR182_5P, MIR4306, MIR6875_3P, MIR5010_3P, MIR577
GO Biological Process (3): regulation of DNA-templated transcription (GO:0006355), gamete generation (GO:0007276), chromatin organization (GO:0006325)
GO Molecular Function (2): histone H3K4me3 reader activity (GO:0140002), protein binding (GO:0005515)
GO Cellular Component (3): nucleoplasm (GO:0005654), cytosol (GO:0005829), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| sexual reproduction | 1 |
| multicellular organismal reproductive process | 1 |
| cellular component organization | 1 |
| histone H3 reader activity | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
438 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPIN3 | FAM228A | Q86W67 | 447 |
| SPIN3 | SPINDOC | Q9BUA3 | 412 |
| SPIN3 | PAX3 | P23760 | 373 |
| SPIN3 | DUXB | A0A1W2PPF3 | 370 |
| SPIN3 | PLS3 | P13797 | 367 |
| SPIN3 | SPNS1 | Q9H2V7 | 355 |
| SPIN3 | FOXA3 | P55318 | 353 |
| SPIN3 | SETDB1 | Q15047 | 349 |
| SPIN3 | KAT7 | O95251 | 348 |
| SPIN3 | GRIPAP1 | Q4V328 | 336 |
| SPIN3 | ZGRF1 | Q86YA3 | 336 |
| SPIN3 | C9JR48 | C9JR48 | 317 |
| SPIN3 | DPRX | A6NFQ7 | 317 |
| SPIN3 | SLC25A47 | Q6Q0C1 | 310 |
| SPIN3 | PUM1 | Q14671 | 305 |
| SPIN3 | ZNF101 | Q8IZC7 | 305 |
IntAct
32 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PFDN4 | PFDN6 | psi-mi:“MI:0914”(association) | 0.730 |
| NUDT1 | ACY1 | psi-mi:“MI:0914”(association) | 0.670 |
| SPINDOC | SPIN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPINDOC | SPIN3 | psi-mi:“MI:0914”(association) | 0.560 |
| ZNF324B | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| NOL9 | IPO5 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF324B | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| SPIN3 | VIM | psi-mi:“MI:0915”(physical association) | 0.400 |
| SPIN3 | NDOR1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SERBP1 | SPIN3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ARRB2 | psi-mi:“MI:0914”(association) | 0.350 | |
| ARHGEF40 | ARHGEF11 | psi-mi:“MI:0914”(association) | 0.350 |
| ATXN7L1 | ELP1 | psi-mi:“MI:0914”(association) | 0.350 |
| DAXX | HAT1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRDM7 | SNRPD2 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| CTBP1 | GSN | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| SCRIB | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| DEFB107A | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
| SPINDOC | TRAF3IP2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (35): SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Proximity Label-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), ATXN7L1 (Affinity Capture-MS), PRDM7 (Affinity Capture-MS)
ESM2 similar proteins: A2Z4C5, A7X680, B8AJL9, F4HVW5, F4I933, F4IV66, F4JR57, K4DF01, P0C7Q8, P13675, Q0WPN7, Q10PL5, Q1ECE0, Q2KI39, Q33BI9, Q4V8J7, Q56A73, Q5JUX0, Q5R997, Q5RA80, Q5RAW7, Q61142, Q6NVE3, Q6YZM6, Q8GVE5, Q8K1L2, Q8L7G0, Q8LJW3, Q8RWD9, Q8RWY4, Q8RY82, Q8W4F0, Q90WG1, Q90WG2, Q93VH2, Q93XX4, Q93YR9, Q944S3, Q94BM7, Q99865
Diamond homologs: P13675, Q2KI39, Q4V8J7, Q56A73, Q5JUX0, Q5R997, Q5RA80, Q5RAW7, Q61142, Q6NVE3, Q8K1L2, Q90WG1, Q90WG2, Q99865, Q9BPZ2, Q9Y657
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
299 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:56994981:C:CT | acceptor_gain | 0.9900 |
| X:56994982:G:T | acceptor_gain | 0.9900 |
| X:56995284:G:A | donor_gain | 0.9900 |
| X:56995293:T:TA | donor_gain | 0.9900 |
| X:56995429:C:A | donor_gain | 0.9900 |
| X:56995290:G:A | donor_gain | 0.9800 |
| X:56995428:T:TA | donor_gain | 0.9800 |
| X:56995460:T:TA | donor_gain | 0.9800 |
| X:56995205:T:TA | donor_gain | 0.9700 |
| X:56995215:C:A | donor_gain | 0.9500 |
| X:56994972:C:CT | acceptor_gain | 0.9400 |
| X:56995245:C:A | donor_gain | 0.9400 |
| X:56995413:A:AC | donor_gain | 0.9400 |
| X:56995244:T:TA | donor_gain | 0.9300 |
| X:56995367:T:TA | donor_gain | 0.9300 |
| X:56995415:G:T | donor_gain | 0.9300 |
| X:56995434:G:A | donor_gain | 0.9300 |
| X:56995346:G:A | donor_gain | 0.9200 |
| X:56994973:A:T | acceptor_gain | 0.9100 |
| X:56995257:G:A | donor_gain | 0.9000 |
| X:56995513:C:CA | donor_gain | 0.8900 |
| X:56995129:T:A | donor_gain | 0.8800 |
| X:56995414:TG:T | donor_gain | 0.8700 |
| X:56995450:T:TA | donor_gain | 0.8600 |
| X:56995443:T:TA | donor_gain | 0.8500 |
| X:56995282:T:TA | donor_gain | 0.8200 |
| X:56995198:C:CA | donor_gain | 0.8100 |
| X:56994949:CCTG:C | acceptor_loss | 0.8000 |
| X:56994950:CT:C | acceptor_loss | 0.8000 |
| X:56994951:T:G | acceptor_loss | 0.8000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000300463 (X:56995734 G>A), RS1000439349 (X:56995455 C>T), RS1000493287 (X:56984278 T>C), RS1000511315 (X:56982090 G>A,C), RS1000703515 (X:56975291 G>A), RS1000790534 (X:56995106 T>A,C), RS1000808765 (X:56995466 T>TGGCGGC), RS1001051465 (X:56974956 C>T), RS1001266897 (X:56979446 G>A), RS1001317362 (X:56979952 T>C), RS1001616711 (X:56989206 G>A), RS1001628775 (X:56986119 G>A), RS1001857423 (X:56974795 T>G), RS1002054275 (X:56997055 C>T), RS1002075280 (X:56982699 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006661_145 | Male-pattern baldness | 6.000000e-19 |
| GCST006979_841 | Heel bone mineral density | 8.000000e-24 |
| GCST009799_6 | Alcohol consumption (drinkers vs non-drinkers) | 2.000000e-08 |
| GCST90002395_636 | Mean platelet volume | 2.000000e-152 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009270 | heel bone mineral density |
| EFO:0004329 | alcohol drinking |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523325 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
3 potent at pChembl≥5 of 3 total, top 3 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.88 | Kd | 131.1 | nM | CHEMBL4451634 |
| 6.77 | Kd | 170 | nM | CHEMBL4552020 |
| 5.85 | Kd | 1400 | nM | CHEMBL5594627 |
PubChem BioAssay actives
3 with measured affinity, of 5 total; 3 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 2-[4-[2-[[2-[3-[2-amino-5-(cyclopropylmethoxy)-3,3-dimethylindol-6-yl]oxypropyl]-1,3-dihydroisoindol-5-yl]oxy]ethyl]triazol-1-yl]-1-[4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]ethanone | 1526488: Binding affinity to recombinant human His-tagged SPIN3 (27 to 258 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by isothermal titration calorimetry | kd | 0.1311 | uM |
| [3-(aminomethyl)-5-[3-(1,3-dihydroisoindol-2-yl)propoxy]-4-methoxyphenyl]methanamine | 1578936: Inhibition of recombinant human N-terminal His6-tagged SPIN3 (27 to 258 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as dissociation constant by isothermal titration calorimetry | kd | 0.1700 | uM |
| N-[7-[3-(1,3-dihydroisoindol-2-yl)propoxy]-6-methoxy-4-pyrrolidin-1-ylquinazolin-2-yl]-N’,N’-dimethylethane-1,2-diamine | 2103452: Binding affinity to human N-terminal His6 tagged SPIN3 (M27 to S258 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by isothermal titration calorimetry | kd | 1.4000 | uM |
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, affects cotreatment, decreases expression | 6 |
| Benzo(a)pyrene | affects methylation, decreases expression | 3 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| entinostat | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| eprenetapopt | affects expression, affects reaction | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
ChEMBL screening assays
4 unique, capped per target: 4 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4323088 | Binding | Binding affinity to recombinant human His-tagged SPIN3 (27 to 258 residues) expressed in Escherichia coli BL21 (DE3) assessed as melting temperature at 20 uM by Sypro orange dye based differential scanning fluorimetry | A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.